Listed as the 2nd largest shareholder
[팜뉴스=이권구 기자] Yuhan Corporation (CEO Jo Wook-je) announced that it was listed as the second largest shareholder by investing an additional 10 billion won in April Bio, which has Serum Albumin Fragment Associated (SAFA) technology, adding its existing stake.
Established in 2013, April Bio is developing global innovative new drugs in various therapeutic areas using its own human antibody library (HuDVFab) technology and SAFA (Serum Albumin Fragment Associated), a sustained platform technology that can increase the half-life of antibody fragment utilization. It is a company specializing in new antibody drugs.
April Bio is preparing for phase 1 clinical trial in the United States this year, APB-A1, a preclinical inflammatory autoimmune disease treatment (IL-18 target), APB-R3, male infertility treatment (FSH target) APB -R2, etc. are being developed.
Recently, it has decided to issue a paid-in capital increase by 10 billion won to Yuhan Corporation. In 2020, it attracted 18 billion won of Series B investment, and at this time Yuhan Corporation as a strategic investor (SI) invested 3 billion won in April Bio to acquire a 4.89% stake.
Since then, Yuhan Corporation and April Bio signed a’Joint Research New Drug Development Business Agreement’ to strengthen research cooperation, and the two companies are strengthening the partnership through additional investment.
An official from Yuhan said,’The reason why Yuhan, an existing strategic investor (SI), made additional investments is that April Bio’s unique platform technology, Serum Albumin Fragment Associated (SAFA), is recognized for its excellence, which will further accelerate joint research using this It’s for” he said.
Meanwhile, April Bio is preparing for a special listing on the KOSDAQ market this year through technology evaluation, and major financial investors are LB Investment, TS Investment, Hana Financial Investment, Ebest Investment & Securities, SJ Investment Partners, Daekyo Investment, Mirae Equity Partners, These include SM Cino Technology Investment, BSK Investment, Wooshin Venture Investment, and Kolon Investment.
Copyright © Farm News Unauthorized reproduction and redistribution prohibited